Blog

Aequs IPO Listing: Strong Start or Early Warning? Full Breakdown Inside

If you’ve been tracking the Indian stock market lately, you’ve probably noticed how IPOs have turned into the country’s new favourite adrenaline rush. Every week brings a fresh listing, a fresh scramble for allotments, and fresh debates in Telegram groups about “listing gain milega kya?” And this week, Aequs Limited stepped right into that spotlight—with […]

Blog

Netflix vs Paramount: The $100 Billion Battle for Warner Bros Discovery

If you’ve ever wondered what a ₹9-lakh-crore showdown looks like in the entertainment world, Hollywood is giving us a front-row seat. The Netflix vs Paramount Skydance battle to acquire Warner Bros Discovery isn’t just another corporate bidding war.It’s a fight that will decide who controls HBO, CNN, DC Comics, and one of the most legendary

Blog

Corona Remedies IPO Falling GMP Explained: Risks, Insights & Wakefit Twist

If you’ve been tracking the markets this week, you may have noticed something unusual: two big names — Corona Remedies and Wakefit Innovations — both opened their IPOs with strong brand recall, but investor sentiment has been surprisingly cautious. The Corona Remedies IPO, despite being backed by a well-known pharmaceutical player, is showing signs of

Blog

Kaynes Technology Share Price Rebounds: Is This the Perfect Re-entry Point?

When a stock crashes nearly 30% in barely a week, most investors don’t sleep well. And when that stock is Kaynes Technology, a favourite in India’s fast-growing electronics manufacturing (EMS) sector, the panic feels personal. WhatsApp groups buzz. Broker apps refresh every 10 seconds. Everyone becomes an amateur forensic accountant overnight. Yet, in one sharp

Scroll to Top